HK1216080A1
(en )
2016-10-14
Compositions and methods for treating or preventing oxalate-related disease
HRP20130782T1
(en )
2013-09-30
Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
EP1962873A4
(en )
2010-08-11
Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
PL1908779T3
(en )
2013-06-28
Thymosin beta 4 derivatives and use thereof
PL1920065T3
(en )
2019-02-28
Anti-alpha v beta 6 antibodies and uses thereof
IL178390A0
(en )
2007-03-08
Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
EP1742640A4
(en )
2008-12-24
Methods and compositions for treating diseases and conditions associated with mitochondrial function
EP1827389A4
(en )
2012-09-12
Sustained-release nanoparticle compositions and methods for using the same
EP1737482A4
(en )
2010-09-15
Compositions and methods for treating diseases
EP1680009A4
(en )
2009-02-11
Compositions and methods for diagnosing and treating mental disorders
EP1589996A4
(en )
2009-01-21
Anti-integrin alpha beta 3 antibody formulat ions and uses thereof
EP1668024A4
(en )
2008-07-02
Oligonucleotide compositions and methods for treating disease including inflammatory conditions
EP1978034A4
(en )
2010-09-01
Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
ZA200707407B
(en )
2008-11-26
Composition for preventing plant diseases and method for preventing the diseases
EP1755537A4
(en )
2009-12-09
Methods and compositions for preventing or treating periodontal diseases
EP1512415A4
(en )
2005-11-09
Decoy composition for treating and preventing inflammatory disease
IL178598A0
(en )
2007-05-15
Skin-protecting alkalinity-controlling composition and the use thereof
EP1583966A4
(en )
2007-06-27
Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061,17662,1468,12282, 6350, 9035,1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123,12788,17729, 65552,1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32
EP1807067A4
(en )
2010-08-18
Sphingosine kinase activator and skin disease treating agent comprising the same
HK1075272A1
(en )
2005-12-09
Dye composition and the use thereof
ME02086B
(en )
2014-02-28
Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
EP1850827A4
(en )
2009-08-12
Composition for treating and preventing periodontal disease and method of use
EP1804795A4
(en )
2007-11-07
Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
EP1829860A4
(en )
2011-06-08
9,10-secopregnane derivative and medicine
PT1965816T
(en )
2017-06-23
Pharmaceutical compositions and methods for treating or preventing oxalate-related disease